249 related articles for article (PubMed ID: 33193356)
1. The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus.
Bortoluzzi A; Chighizola CB; Fredi M; Raschi E; Bodio C; Privitera D; Gonelli A; Silvagni E; Govoni M; Cavazzana I; Airò P; Meroni PL; Tincani A; Franceschini F; Piantoni S; Casciano F
Front Immunol; 2020; 11():572876. PubMed ID: 33193356
[TBL] [Abstract][Full Text] [Related]
2. Senescent profile of angiogenic T cells from systemic lupus erythematosus patients.
López P; Rodríguez-Carrio J; Martínez-Zapico A; Caminal-Montero L; Suarez A
J Leukoc Biol; 2016 Mar; 99(3):405-12. PubMed ID: 26232454
[TBL] [Abstract][Full Text] [Related]
3. Circulating Angiogenic T Cells and Their Subpopulations in Patients with Systemic Lupus Erythematosus.
Miao J; Qiu F; Li T; Zhao P; Zhang K; Lv M; Wan J; Qi X; Zhu P
Mediators Inflamm; 2016; 2016():2842143. PubMed ID: 27065298
[TBL] [Abstract][Full Text] [Related]
4. Circulating Angiogenic T Cells Are Increased in Lupus Nephritis Patients.
Zhao P; Miao J; Zhang K; Lv M; Han Q; Zhu P
Med Sci Monit; 2018 Aug; 24():5384-5390. PubMed ID: 30072685
[TBL] [Abstract][Full Text] [Related]
5. Imbalance between CD8
Minning S; Xiaofan Y; Anqi X; Bingjie G; Dinglei S; Mingshun Z; Juan X; Xiaohui J; Huijuan W
Lupus; 2019 Sep; 28(10):1214-1223. PubMed ID: 31399013
[TBL] [Abstract][Full Text] [Related]
6. Relationship between endothelial dysfunction, videocapillaroscopy and circulating CD3+CD31+CXCR4+ lymphocytes in systemic lupus erythematosus without cardiovascular risk factors.
Cavazzana I; Piantoni S; Sciatti E; Fredi M; Taraborelli M; Bonadei I; Airò P; Metra M; Tincani A; Franceschini F; Vizzardi E
Lupus; 2019 Feb; 28(2):210-216. PubMed ID: 30608206
[TBL] [Abstract][Full Text] [Related]
7. Effector T-cells are expanded in systemic lupus erythematosus patients with high disease activity and damage indexes.
Piantoni S; Regola F; Zanola A; Andreoli L; Dall'Ara F; Tincani A; Airo' P
Lupus; 2018 Jan; 27(1):143-149. PubMed ID: 28764616
[TBL] [Abstract][Full Text] [Related]
8. CD4
Kosmaczewska A; Ciszak L; Stosio M; Szteblich A; Madej M; Frydecka I; Wiland P; Szmyrka M
Lupus; 2020 Jun; 29(7):705-714. PubMed ID: 32279585
[TBL] [Abstract][Full Text] [Related]
9. CD3
Mohd Shukri ND; Farah Izati A; Wan Ghazali WS; Che Hussin CM; Wong KK
Front Immunol; 2021; 12():675250. PubMed ID: 34149710
[TBL] [Abstract][Full Text] [Related]
10. Older men display elevated levels of senescence-associated exercise-responsive CD28
Ross M; Ingram L; Taylor G; Malone E; Simpson RJ; West D; Florida-James G
Physiol Rep; 2018 Jun; 6(12):e13697. PubMed ID: 29939490
[TBL] [Abstract][Full Text] [Related]
11. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
12. Increased interleukin-23 receptor(+) T cells in peripheral blood mononuclear cells of patients with systemic lupus erythematosus.
Puwipirom H; Hirankarn N; Sodsai P; Avihingsanon Y; Wongpiyabovorn J; Palaga T
Arthritis Res Ther; 2010; 12(6):R215. PubMed ID: 21110900
[TBL] [Abstract][Full Text] [Related]
13. Low-density granulocytes and monocytes as biomarkers of cardiovascular risk in systemic lupus erythematosus.
López P; Rodríguez-Carrio J; Martínez-Zapico A; Pérez-Álvarez ÁI; Suárez-Díaz S; Mozo L; Benavente L; Caminal-Montero L; Suárez A
Rheumatology (Oxford); 2020 Jul; 59(7):1752-1764. PubMed ID: 32031658
[TBL] [Abstract][Full Text] [Related]
14. Activated Platelets Induce Endothelial Cell Activation via an Interleukin-1β Pathway in Systemic Lupus Erythematosus.
Nhek S; Clancy R; Lee KA; Allen NM; Barrett TJ; Marcantoni E; Nwaukoni J; Rasmussen S; Rubin M; Newman JD; Buyon JP; Berger JS
Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):707-716. PubMed ID: 28153882
[TBL] [Abstract][Full Text] [Related]
15. Circulating senescent angiogenic T cells are linked with endothelial dysfunction and systemic inflammation in hypertension.
Zhang G; Liu Y; Qiu Y; Zhang J; Sun J; Zhou Z; Wang Z; Zeng P; Tao J; He J
J Hypertens; 2021 May; 39(5):970-978. PubMed ID: 33196557
[TBL] [Abstract][Full Text] [Related]
16. Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus.
Kahlenberg JM; Thacker SG; Berthier CC; Cohen CD; Kretzler M; Kaplan MJ
J Immunol; 2011 Dec; 187(11):6143-56. PubMed ID: 22058412
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate improves endothelial function in early rheumatoid arthritis patients after 3 months of treatment.
Cafaro G; Petito E; Bistoni O; Falcinelli E; Cipriani S; Borghi MC; Bonifacio AF; Giglio E; Alunno A; Perricone C; Gerli R; Gresele P; Bartoloni E
Arthritis Res Ther; 2022 Oct; 24(1):236. PubMed ID: 36280849
[TBL] [Abstract][Full Text] [Related]
18. Melatonin prevents endothelial dysfunction in SLE by activating the nuclear receptor retinoic acid-related orphan receptor-α.
Huang H; Liu X; Chen D; Lu Y; Li J; Du F; Zhang C; Lu L
Int Immunopharmacol; 2020 Jun; 83():106365. PubMed ID: 32172204
[TBL] [Abstract][Full Text] [Related]
19. The risk of circulating angiogenic T cells and subsets in patients with systemic sclerosis.
Lv T; Yang F; Zhang K; Lv M; Zhang Y; Zhu P
Int Immunopharmacol; 2020 Apr; 81():106282. PubMed ID: 32066116
[TBL] [Abstract][Full Text] [Related]
20. Angiogenic T cells are decreased in rheumatoid arthritis patients.
Rodríguez-Carrio J; Alperi-López M; López P; Alonso-Castro S; Ballina-García FJ; Suárez A
Ann Rheum Dis; 2015 May; 74(5):921-7. PubMed ID: 24399233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
